IRIS
CICONTE, GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.599
AS - Asia 1.460
NA - Nord America 1.027
SA - Sud America 358
AF - Africa 45
Continente sconosciuto - Info sul continente non disponibili 3
Totale 4.492
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 968
RU - Federazione Russa 961
SG - Singapore 570
CN - Cina 389
BR - Brasile 297
IT - Italia 187
HK - Hong Kong 183
VN - Vietnam 150
SE - Svezia 126
DE - Germania 77
FR - Francia 64
GB - Regno Unito 47
FI - Finlandia 35
IN - India 33
CA - Canada 30
AR - Argentina 24
BD - Bangladesh 23
MX - Messico 21
JP - Giappone 20
AT - Austria 19
NL - Olanda 17
PL - Polonia 17
ID - Indonesia 16
ZA - Sudafrica 15
TR - Turchia 13
IE - Irlanda 12
EC - Ecuador 11
LT - Lituania 11
MA - Marocco 8
OM - Oman 8
BE - Belgio 7
ES - Italia 7
IQ - Iraq 7
KE - Kenya 7
PK - Pakistan 7
CO - Colombia 6
SA - Arabia Saudita 6
EG - Egitto 5
VE - Venezuela 5
CL - Cile 4
PH - Filippine 4
PY - Paraguay 4
UZ - Uzbekistan 4
AZ - Azerbaigian 3
EU - Europa 3
IR - Iran 3
NP - Nepal 3
PE - Perù 3
PT - Portogallo 3
SN - Senegal 3
TN - Tunisia 3
UA - Ucraina 3
AE - Emirati Arabi Uniti 2
BH - Bahrain 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
JO - Giordania 2
LB - Libano 2
MY - Malesia 2
QA - Qatar 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AL - Albania 1
AM - Armenia 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DM - Dominica 1
DZ - Algeria 1
GE - Georgia 1
GP - Guadalupe 1
IM - Isola di Man 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LY - Libia 1
MD - Moldavia 1
ME - Montenegro 1
MN - Mongolia 1
NI - Nicaragua 1
TL - Timor Orientale 1
TZ - Tanzania 1
ZM - Zambia 1
Totale 4.492
Salva come PNG Salva come JPEG
Città #
Singapore 266
Moscow 205
Hong Kong 182
Ashburn 176
Dallas 151
San Jose 125
Shanghai 81
Hefei 66
Milan 65
Beijing 63
Ho Chi Minh City 56
Lauterbourg 56
Lawrence 46
Princeton 45
New York 40
São Paulo 30
Los Angeles 26
Orem 26
Hanoi 23
Helsinki 21
London 18
Nuremberg 17
Tokyo 17
Chennai 15
Rome 15
Santa Clara 15
Warsaw 15
Boardman 13
Frankfurt am Main 13
Denver 12
Phoenix 12
Vienna 12
Cesano Boscone 11
Dublin 11
Haiphong 11
Montreal 11
Toronto 11
Amsterdam 10
Seattle 9
Biên Hòa 8
Munich 8
Stockholm 8
Ankara 7
Atlanta 7
Brasília 7
Brescia 7
Brooklyn 7
Falkenstein 7
Johannesburg 7
Manchester 7
San Francisco 7
Turku 7
Belo Horizonte 6
Lappeenranta 6
Mexico City 6
Muscat 6
Nairobi 6
Rio de Janeiro 6
Salvador 6
Chicago 5
Curitiba 5
Ferrara 5
Guangzhou 5
Kassel 5
Naples 5
Poplar 5
Recife 5
Viareggio 5
Wolfhagen 5
Aracaju 4
Brussels 4
City of London 4
Da Nang 4
Goiânia 4
Guarulhos 4
Hangzhou 4
Jakarta 4
Mumbai 4
New Delhi 4
Paris 4
Porto Alegre 4
Quito 4
Tashkent 4
The Dalles 4
Vilnius 4
Asunción 3
Baghdad 3
Baku 3
Bologna 3
Campinas 3
Cape Town 3
Casablanca 3
Dakar 3
Dammam 3
Dhaka 3
Diadema 3
Ha Long 3
Houston 3
Irecê 3
Istanbul 3
Totale 2.292
Salva come PNG Salva come JPEG
Nome #
Challenges in Brugada Syndrome Stratification: Investigating SCN5A Mutation Localization and Clinical Phenotypes 119
Brugada Syndrome: New Insights From Cardiac Magnetic Resonance and Electroanatomical Imaging 116
Unravelling Novel SCN5A Mutations Linked to Brugada Syndrome: Functional, Structural, and Genetic Insights 114
Human Sarcopenic Myoblasts Can Be Rescued by Pharmacological Reactivation of HIF-1α 113
Brugada syndrome genetics is associated with phenotype severity 112
Ebstein's anomaly in children and adults: Multidisciplinary insights into imaging and therapy 105
Analysis of the intramolecular 1,7-lactone of N-acetylneuraminic acid using HPLC–MS: relationship between detection and stability 101
Cell-Based Therapies for Cardiac Regeneration: A Comprehensive Review of Past and Ongoing Strategies 100
Arrhythmogenic substrate elimination for safe testosterone therapy in symptomatic Brugada syndrome patients 97
Brugada Syndrome: Warning of a Systemic Condition? 94
Atrial fibrillation in autoimmune rheumatic diseases: From pathogenesis to treatment 94
HIF-1α Directly Controls WNT7A Expression During Myogenesis 94
Comparable clinical characteristics in Brugada syndrome patients harboring SCN5A or novel SCN10A variants 92
GM1 Ganglioside Promotes Osteogenic Differentiation of Human Tendon Stem Cells 91
Clinical characteristics and electrophysiologic properties of SCN5A variants in fever-induced Brugada syndrome 90
Brugada Syndrome Phenotype Elimination by Epicardial Substrate Ablation 89
Clinical considerations for a family with dilated cardiomyopathy, sudden cardiac death, and a novel ttn frameshift mutation 89
Second-generation laser balloon ablation for the treatment of atrial fibrillation assessed by continuous rhythm monitoring: the LIGHT-AF study 87
Neu3 Sialidase Activates the RISK Cardioprotective Signaling Pathway during Ischemia and Reperfusion Injury (IRI) 82
Brugada Syndrome: Oligogenic or Mendelian Disease? 80
Left Atrial Dynamics During Exercise in Mitral Regurgitation of Primary and Secondary Origin: Pathophysiological Insights by Exercise Echocardiography Combined With Gas Exchange Analysis 79
Atrial fibrillation detection using a novel three-vector cardiac implantable monitor: The atrial fibrillation detect study 79
Genotype/Phenotype Relationship in a Consanguineal Family With Brugada Syndrome Harboring the R1632C Missense Variant in the SCN5A Gene 76
Novel scn5a p.V1429m variant segregation in a family with brugada syndrome 75
Intermittent alternance of Brugada ECG patterns: Insights from a unique electrophysiological phenomenon 73
NaV1.5 autoantibodies in Brugada syndrome: pathogenetic implications 72
Atrial fibrillation recurrences during the blanking period after catheter ablation with the laser balloon technique 72
Clinical outcome of electrophysiologically guided ablation for nonparoxysmal atrial fibrillation using a novel real-time 3-dimensional mapping technique results from a prospective randomized trial 72
Right ventricular epicardial arrhythmogenic substrate in long-QT syndrome patients at risk of sudden death 69
Commentary: Next generation sequencing and linkage analysis for the molecular diagnosis of a novel overlapping syndrome characterized by hypertrophic cardiomyopathy and typical electrical instability of brugada syndrome 68
Atrial fibrillation progression and management: a 5-year prospective follow-up study 68
Asymptomatic ventricular preexcitation: a long-term prospective follow-up study of 293 adult patients 67
Assessing QT interval in COVID-19 patients:safety of hydroxychloroquine-azithromycin combination regimen 67
Regenerating the human heart : direct reprogramming strategies and their current limitations 66
Assessing the Malignant Ventricular Arrhythmic Substrate in Patients With Brugada Syndrome 64
Electrical Substrate Elimination in 135 Consecutive Patients with Brugada Syndrome 64
New electromechanical substrate abnormalities in high-risk patients with Brugada syndrome 64
Novel scn5a p.Val1667asp missense variant segregation and characterization in a family with severe brugada syndrome and multiple sudden deaths 64
Non-invasive assessment of the arrhythmogenic substrate in Brugada syndrome using signal-averaged electrocardiogram: Clinical implications from a prospective clinical trial 62
Feasibility of Remote Monitoring Using a Novel Long-Dipole Insertable Cardiac Monitor 61
Congenital coronary artery anomalies: Differential diagnosis of ventricular arrhythmias in young athletes 60
Deep learning unmasks the ECG signature of Brugada syndrome 60
Epicardial arrhythmogenic substrate in long QT syndrome 60
SCN5A nonsense mutation and NF1 frameshift mutation in a family with brugada syndrome and neurofibromatosis 59
Genotype-Phenotype Correlation in a Family with Brugada Syndrome Harboring the Novel p.Gln371* Nonsense Variant in the SCN5A Gene 59
General Anesthesia Attenuates Brugada Syndrome Phenotype Expression: Clinical Implications From a Prospective Clinical Trial 58
Electrocardiographic temporo-spatial assessment of depolarization and repolarization changes after epicardial arrhythmogenic substrate ablation in Brugada syndrome 57
The natural history of asymptomatic ventricular pre-excitation a long-term prospective follow-up study of 184 asymptomatic children 55
Novel SCN5A Frameshift Mutation in Brugada Syndrome Associated With Complex Arrhythmic Phenotype 54
Novel scn5a p.W697x nonsense mutation segregation in a family with brugada syndrome 54
Thrombosis on a left atrial appendage occluder device: The double-edged sword of stroke prevention strategies in atrial fibrillation 53
New-onset atrial fibrillation as first clinical manifestation of latent Brugada syndrome: Prevalence and clinical significance 51
Out-of-hospital cardiac arrest due to idiopathic ventricular fibrillation in patients with normal electrocardiograms: Results from a multicentre long-term registry 50
Unusual response to ajmaline test in Brugada syndrome patient leads to extracorporeal membrane oxygenator support 50
Multipoint left ventricular pacing improves response to cardiac resynchronization therapy with and without pressure-volume loop optimization: comparison of the long-term efficacy of two different programming strategies 50
Safety and feasibility of a novel multielectrode array catheter in mapping atrial and ventricular arrhythmias with high density: results from the multicenter OPTIMUM study 49
Role of sialidase Neu3 and ganglioside GM3 in cardiac fibroblasts activation 48
Multipoint pacing improves peripheral hemodynamic response: Noninvasive assessment using radial artery tonometry 46
Novel CineECG Derived from Standard 12-Lead ECG Enables Right Ventricle Outflow Tract Localization of Electrical Substrate in Patients with Brugada Syndrome 44
The role of implantable cardiac monitors in atrial fibrillation management 42
Reversine: A Synthetic Purine with a Dual Activity as a Cell Dedifferentiating Agent and a Selective Anticancer Drug 42
Common modulators of Brugada syndrome phenotype do not affect SCN5A prognostic value 41
Non-paroxysmal atrial fibrillation mapping: characterization of the electrophysiological substrate using a novel integrated mapping technique 41
Right ventricular electromechanical abnormalities in Brugada syndrome: is this a cardiomyopathy? 40
Epicardial ablation in genetic cardiomyopathies: A new frontier 34
Ablation of the epicardial substrate in patients with long-QT syndrome at risk of sudden death 7
High-risk Brugada syndrome: Factors associated with arrhythmia recurrence and benefits of epicardial ablation in addition to implantable cardioverter defibrillator implantation 7
Anatomical-guided third-generation laser balloon ablation for the treatment of paroxysmal atrial fibrillation assessed by continuous rhythm monitoring: results from a multicentre prospective study 4
Ablation of ventricular arrhythmias in cardiogenetic diseases 4
Continuous Rhythm Monitoring With Implanted Loop Recorders in Children and Adolescents With Brugada Syndrome 3
The “arrhythmic” presentation of peripartum cardiomyopathy: case series and critical review of the literature 2
Mode and Characteristics of Arrhythmia Initiation in Idiopathic Ventricular Fibrillation: A THESIS Substudy 2
Totale 4.627
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.670
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.670
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202236 0 0 0 12 0 1 15 1 6 0 0 1
2022/2023264 112 49 15 7 2 34 10 8 20 5 2 0
2023/2024155 2 4 14 44 12 14 5 15 0 6 13 26
2024/20251.067 140 47 7 34 58 75 126 124 164 124 64 104
2025/20263.055 203 251 239 461 266 89 290 216 888 152 0 0
Totale 4.627